Triggering receptor expressed on myeloid cells 2 (TREM2) is a central regulator of microglial activity and loss-of-function coding variants are major risk factors for late onset Alzheimer's disease (LOAD). This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.